Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,869 | -3,572 | -1,601 | -11,164 | -6,665 |
| Depreciation Amortization | 494 | 327 | 164 | 539 | 370 |
| Accounts receivable | -812 | -242 | -319 | 437 | 289 |
| Accounts payable and accrued liabilities | -253 | -274 | -285 | 228 | 161 |
| Other Working Capital | -1,605 | -1,820 | -1,382 | 247 | -102 |
| Other Operating Activity | 2,191 | 1,238 | 838 | 4,010 | 1,883 |
| Operating Cash Flow | $-2,854 | $-4,343 | $-2,585 | $-5,703 | $-4,064 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -332 | -246 | -85 | -1,461 | -1,154 |
| Purchase Sale Intangibles | -46 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -46 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-378 | $-246 | $-85 | $-1,461 | $-1,154 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -18 | -12 | -6 | -20 | -14 |
| Common Stock Issued | 4,489 | 4,467 | 4,515 | 5,447 | 5,447 |
| Other Financing Activity | 0 | 0 | 0 | -17 | -17 |
| Financing Cash Flow | $4,471 | $4,455 | $4,509 | $5,410 | $5,416 |
| Exchange Rate Effect | 7 | 14 | -22 | 62 | 58 |
| Beginning Cash Position | 3,971 | 3,971 | 3,971 | 5,663 | 5,663 |
| End Cash Position | 5,217 | 3,851 | 5,788 | 3,971 | 5,919 |
| Net Cash Flow | $1,246 | $-120 | $1,817 | $-1,692 | $256 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,854 | -4,343 | -2,585 | -5,703 | -4,064 |
| Capital Expenditure | -332 | -246 | -85 | -1,491 | -1,154 |
| Free Cash Flow | -3,186 | -4,589 | -2,670 | -7,194 | -5,218 |